Get started
Author

James Wilton

Use of an HIV‐risk screening tool to identify optimal candidates for PrEP scale‐up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk
2016 · James Wilton, Taylor Kain, et al. · Journal of the International AIDS Society · 127
PDF
Association of COVID-19 Infection With Incident Diabetes
2023 · Zaeema Naveed, Héctor A. Velásquez García, et al. · JAMA Network Open · 73
PDF
Preparing for PrEP: Perceptions and Readiness of Canadian Physicians for the Implementation of HIV Pre-Exposure Prophylaxis
2014 · Malika Sharma, James Wilton, et al. · PLoS ONE · 72
PDF
Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study
2021 · Naveed Z. Janjua, Stanley Wong, et al. · Journal of Hepatology · 67
Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review
2015 · Darrell Tan, Heather Senn, et al. · HIV/AIDS - Research and Palliative Care · 51
PDF
Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999–2013)
2018 · J Wilton, L Light, et al. · HIV Medicine · 43
Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study
2022 · Zaeema Naveed, Julia Li, et al. · Canadian Medical Association Journal · 42
PDF
Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study
2020 · James Wilton, Stanley Wong, et al. · Open Forum Infectious Diseases · 39
PDF
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol
2018 · Malika Sharma, Allison Chris, et al. · BMC Health Services Research · 37
PDF
Decentralizing PrEP delivery: Implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada
2021 · Maxime Charest, Malika Sharma, et al. · PLoS ONE · 36
PDF
Awareness of, interest in, and willingness to pay for HIV pre-exposure prophylaxis among Canadian gay, bisexual, and other men who have sex with men
2018 · Jeffrey Morgan, Olivier Ferlatte, et al. · Canadian Journal of Public Health · 36
PDF
Trends in the awareness, acceptability, and usage of HIV pre-exposure prophylaxis among at-risk men who have sex with men in Toronto
2018 · Jayoti Rana, James Wilton, et al. · Canadian Journal of Public Health · 36
PDF
Trends in HIV pre-exposure prophylaxis uptake in Ontario, Canada, and impact of policy changes: a population-based analysis of projected pharmacy data (2015–2018)
2020 · Darrell H. S. Tan, Thomas M. Dashwood, et al. · Canadian Journal of Public Health · 35
PDF
Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
2022 · Zaeema Naveed, Julia Li, et al. · Journal of the American College of Cardiology · 31
PDF
Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would Benefit Most From PrEP
2017 · James Wilton, Sharmistha Mishra, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 30
Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: A retrospective, population-based cohort study
2019 · James Wilton, Juan Liu, et al. · PLoS ONE · 27
PDF
Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study
2021 · James Wilton, Younathan Abdia, et al. · BMJ · 26
PDF
Knowledge of and Opinions on HIV Preexposure Prophylaxis Among Front-Line Service Providers at Canadian AIDS Service Organizations
2013 · Heather Senn, James Wilton, et al. · AIDS Research and Human Retroviruses · 26
Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases
2022 · Sean P Harrigan, James Wilton, et al. · Clinical Infectious Diseases · 25
The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study
2021 · Sofia R Bartlett, Stanley Wong, et al. · Clinical Infectious Diseases · 23
HCV reinfection rates after cure or spontaneous clearance among HIV‐infected and uninfected men who have sex with men
2020 · Prince A. Adu, Carmine Rossi, et al. · Liver International · 22
Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis
2015 · Deborah Yoong, Mark Naccarato, et al. · International Journal of STD & AIDS · 22
Cohort profile: the British Columbia COVID-19 Cohort (BCC19C)—a dynamic, linked population-based cohort
2024 · James Wilton, Jalud Abdulmenan, et al. · Frontiers in Public Health · 20
Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design
2022 · Adeleke Fowokan, Hasina Samji, et al. · International Journal of Infectious Diseases · 20
High HIV risk and syndemic burden regardless of referral source among MSM screening for a PrEP demonstration project in Toronto, Canada
2018 · James Wilton, Syed W. Noor, et al. · BMC Public Health · 20
PDF
Works count: 84
Citation count: 1,231
H-index: 22
I10-index: 33
Year
Topic
Type